Pharmaceutical Portfolio


Chemic Laboratories after more than 15 years of compound development, our Synthetic Chemistry & Discovery business unit has announced the launch of its API portfolio. With the collection approaching 400 compounds in numerous indication categories, Chemic Laboratories is now aggressively seeking out “Industry Partners” to jointly move select compounds further along the drug development pipeline.

Pharmaceutical Portfolio

Please contact Joseph St.Laurent, President, CSO for further inquiries:JPS@Chemiclabs.com